Taxes on Income - Schedule of Reconcile the Statutory Income Tax Rate to Effective Income Tax Rate (Details) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Income Tax Disclosure [Abstract] | |||
Tax rate | 23.00% | 23.00% | 24.00% |
Tax expense (benefit) at statutory rate | $ 2,054,113 | $ 105,234 | $ 642,090 |
Tax rate differential | 28,057 | ||
Change in taxes from permanent differences in stock-based compensation | 639,504 | 10,964 | 27,301 |
Change in taxes from permanent difference in derivative warrants liabilities and convertible loans | 858,307 | (212,959) | 304,254 |
Change in temporary differences | 111,480 | ||
Others | 1,925 | ||
Loss carryforwards | 442,897 | 307,229 | 282,478 |
Income tax expense (benefit) |
X | ||||||||||
- Definition Increase in temporary differences. No definition available.
|
X | ||||||||||
- Definition Loss carryforwards. No definition available.
|
X | ||||||||||
- Definition Increase in taxes from permanent difference in derivative warrants liabilities and convertible loans. No definition available.
|
X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|